Where NeoGenomics Stands With Analysts
Where NeoGenomics Stands With Analysts
NeoGenomics 在分析師中的立場
Ratings for NeoGenomics (NASDAQ:NEO) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
在過去三個月中，有4位分析師提供了NeoGenomics（納斯達克股票代碼：NEO）的評級，顯示了看漲和看跌的觀點。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您將找到他們最近的評級摘要，揭示了過去30天中情緒的變化，並將其與前幾個月進行了比較。
Insights from analysts' 12-month price targets are revealed, presenting an average target of $20.5, a high estimate of $24.00, and a low estimate of $19.00. This current average reflects an increase of 2.5% from the previous average price target of $20.00.
分析師12個月目標股價的見解已經公佈，平均目標股價爲20.5美元，最高估計爲24.00美元，低估值爲19.00美元。目前的平均價格比之前的平均目標股價20.00美元增長了2.5％。
Breaking Down Analyst Ratings: A Detailed Examination
分解分析師評級：詳細審查
In examining recent analyst actions, we gain...
在研究分析師最...
登入免費觀看全文
登入/註冊